Why MasterBrand Inc (NYSE:MBC) Stock declined -10.78% in Last Three Months?

Loop Capital raised the price target for the MasterBrand Inc (NYSE:MBC) stock from “a Hold” to “a Buy”. The rating was released on May 10, 2023, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -0.74% within the last five trades and -6.03% within […]

Adient plc (NYSE:ADNT) stock is trading -40.57 percent below its 52-week high

Barclays lowered the price target for the Adient plc (NYSE:ADNT) stock from “an Overweight” to “an Equal weight”. The rating was released on April 10, 2024, according to finviz. The stock was initiated by Barclays, who disclosed in a research note on February 15, 2023, to Overweight and set the price objective to $57. The […]

Envista Holdings Corp (NYSE:NVST) Stock is trading at a margin of -1.93% From 20-Day SMA

Morgan Stanley lowered the price target for the Envista Holdings Corp (NYSE:NVST) stock from “an Overweight” to “an Equal-weight”. The rating was released on April 26, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $23. In their research brief published […]

Vtex (NYSE:VTEX) Stock Price Settled at $6.72: What’s Resulting?

JP Morgan raised the price target for the Vtex (NYSE:VTEX) stock from “a Neutral” to “an Overweight”. The rating was released on May 14, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight with a […]

Neurocrine Biosciences, Inc. (NBIX) Stock Is Emerging from the Clouds

Wells Fargo raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock from “an Equal weight” to “an Overweight”. The rating was released on April 24, 2024, according to finviz. The research report from Deutsche Bank has initiated the stock to Buy, with a price target set at $136. The stock was resumed by […]

Earnings and valuation of Hubbell Inc. (HUBB) Stock are impressive

Deutsche Bank raised the price target for the Hubbell Inc. (NYSE:HUBB) stock to “a Hold”. The rating was released on March 11, 2024, according to finviz. The research report from Barclays has initiated the stock to Equal Weight, with a price target set at $325. The stock was upgraded by JP Morgan, who disclosed in […]

Healthequity Inc (HQY) Stock Experiences Incredible Growth

JMP Securities raised the price target for the Healthequity Inc (NASDAQ:HQY) stock to “a Mkt outperform”. The rating was released on April 04, 2024, according to finviz. We previously noted in another research note published on April 02, 2024 by JP Morgan that reiterated the stock to an Overweight with a price target of $108 […]

Cactus Inc (WHD) Stock is more thoughtful than you think

Johnson Rice raised the price target for the Cactus Inc (NYSE:WHD) stock from “a Buy” to “a Accumulate”. The rating was released on May 31, 2024, according to finviz. The research report from Barclays has upgraded the stock from Equal Weight to Overweight, with a price target set at $60. The stock was downgraded by […]